NCT02666404

Brief Summary

Volume resuscitation is the mainstay of treatment in most types of shock, especially in hemorrhagic and septic shock. Septic shock is a main cause of morbidity and mortality worldwide. Although there has been a lot of research to evaluate optimal amount and composition of fluids for volume resuscitation (e.g. colloids, crystalloids, red blood cell transfusion, albumin, fresh frozen plasma) particularly in the past decade, results remain inconclusive and to some extent contradictive. The investigators would like to contribute to the establishment of new endpoints for the guidance of shock therapy focusing on the first 24 and 48 hours, amending the currently used parameters (i.e. cardiac output, heart rate, blood pressure, central venous pressure) with new measurements (see study specific measurements). The goal is to decrease the need for renal replacement therapy, thereby eventually reducing patient morbidity and mortality.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

January 18, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 28, 2016

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 18, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 18, 2021

Completed
Last Updated

April 1, 2021

Status Verified

March 1, 2021

Enrollment Period

5.2 years

First QC Date

January 18, 2016

Last Update Submit

March 29, 2021

Conditions

Keywords

Volume ResuscitationShockBody Impedance MeasurementRenal Resistive IndexAcute Kidney InjuryRenal Replacement Therapy

Outcome Measures

Primary Outcomes (1)

  • Acute kidney injury (KDIGO staging for severity of acute kidney injury ).

    Change in renal function from baseline according to KDIGO staging

    Assessment at 0, 6, 24, 48, and 72 hours after shock diagnosis

Secondary Outcomes (6)

  • Difference in lactate values (µmol/l)

    Between 6 and 24 hours after admittance to the ICU and baseline (t1/t2 - t0)

  • Need for renal replacement therapy (KDIGO staging for severity of acute kidney injury)

    Assessment at 0, 6, 24, 48, and 72 hours after shock diagnosis

  • Length of ICU stay

    1 month

  • Length of hospital stay

    1 month

  • Need for mechanical ventilation

    During 27 hours

  • +1 more secondary outcomes

Study Arms (1)

Volume Resuscitation

EXPERIMENTAL

We would like to establish new endpoints for guidance of volume resuscitation by implementing new measurements (body impedance, renal resistive index).

Other: Measurement

Interventions

We will perform those new measurements and assessments for guidance of fluid resuscitation at 0, 6, 24, 48, and 72 hours after shock diagnosis and concomitant fulfillment of eligibility requirements

Also known as: Body Impedance Measurement, Renal Resistive Index, Intra-abdominal Pressure
Volume Resuscitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • State of shock (any type) upon admittance to the ICU.

You may not qualify if:

  • Age below 18 years
  • Non-shock state
  • Terminal state
  • Pregnancy
  • Jehovah's Witnesses

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Basel

Basel, 4031, Switzerland

Location

MeSH Terms

Conditions

ShockAcute Kidney Injury

Interventions

Weights and Measures

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Martin Siegemund, MD

    Deputy Chief Physician, Surgical Intensive Care Unit

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 18, 2016

First Posted

January 28, 2016

Study Start

January 1, 2016

Primary Completion

March 18, 2021

Study Completion

March 18, 2021

Last Updated

April 1, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will share

Average Acute Physiology And Chronic Health Evaluation (APACH) II score/SAPS II score/SOFA score/KDIGO criteria

Locations